Farms.com Home   News

Misconceptions of Chemical Use on Crops

Technology and research advancements have changed how farmers use chemicals on their crops. Even with these improvements, there’s a lot of misinformation out there amongst consumers about how chemicals are used on crops.

On the Dec. 14 episode of Seed Speaks, we’re taking a closer look at what the ag industry do to stop these rumours dead in their tracks. We’re joined by Ian Affleck, vice-president of plant biotechnology at CropLife Canada, and Stuart Smyth, an associate professor in the Department of Agricultural and Resource Economics at the University of Saskatchewan (U of S).

Affleck works with domestic and international agricultural stakeholders and governments on the development of policies, regulations, and science related to plant biotechnology. Prior to CropLife Canada, he worked at the Canadian Food Inspection Agency for 10 years, focusing on the regulation of novel plants and new varieties. Affleck has a bachelor of science in agriculture from the Nova Scotia Agricultural College, and a master’s degree in agriculture from the University of Guelph.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.